A mitochondrial blood-based patient stratification candidate biomarker for Parkinson’s disease (original) (raw)
Circulating cell-free mitochondrial DNA levels in Parkinson’s disease are influenced by treatment
Andrés Caicedo
Molecular Neurodegeneration, 2020
View PDFchevron_right
Analysis of mitochondrial DNA allelic changes in Parkinson’s disease: a preliminary study
fiorenzo conti
Aging Clinical and Experimental Research, 2019
View PDFchevron_right
Mitochondrial DNA Deletions/Rearrangements in Parkinson Disease and Related Neurodegenerative Disorders
G. Gu
Journal of Neuropathology & Experimental Neurology, 2002
View PDFchevron_right
Mitochondrial DNA analysis in Parkinson's disease
Mary Sweeney
Movement Disorders, 1990
View PDFchevron_right
Mitochondrial DNA damage as a potential biomarker of LRRK2 kinase activity in LRRK2 Parkinson’s disease
sylviane boularand
Scientific Reports, 2020
View PDFchevron_right
Mitochondrial alterations in Parkinson’s disease: new clues
Celine Perier
Journal of Neurochemistry, 2008
View PDFchevron_right
Mitochondrial DNA damage triggers spread of Parkinson’s disease-like pathology
Shohreh Issazadeh-Navikas
Molecular Psychiatry
View PDFchevron_right
Mitochondrial Respiratory Chain Enzyme Activities , mtDNA Variants and Gene Expression Levels in Idiopathic Parkinson ’ s Disease
Levent Inan
2009
View PDFchevron_right
A genome on shaky ground: exploring the impact of mitochondrial DNA integrity on Parkinson’s disease by highlighting the use of cybrid models
Andrew Hicks
Cellular and Molecular Life Sciences, 2022
View PDFchevron_right
mRNA expression profiling of mitochondrial subunits in subjects with Parkinson’s disease
Giuseppe Lanza
Archives of Medical Science
View PDFchevron_right
Parkinson’s Disease: A Complex Interplay of Mitochondrial DNA Alterations and Oxidative Stress
Giovanna Bellusci
International Journal of Molecular Sciences, 2013
View PDFchevron_right
Mitochondrial dysfunction is a key pathological driver of early stage Parkinson’s
iain hargreaves
Acta Neuropathologica Communications
View PDFchevron_right
Altered Transcriptional Profile of Mitochondrial DNA-Encoded OXPHOS Subunits, Mitochondria Quality Control Genes, and Intracellular ATP Levels in Blood Samples of Patients with Parkinson’s Disease
HULYA APAYDIN
Journal of Alzheimer's Disease, 2020
View PDFchevron_right
Two-stage association study and meta-analysis of mitochondrial DNA variants in Parkinson disease
Caroline H Williams-Gray
Neurology, 2013
View PDFchevron_right
Parkinson's disease and mitochondrial gene variations: A review
Andres Mesa
View PDFchevron_right
Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis
j Martinez
2009
View PDFchevron_right
Do somatic mitochondrial DNA mutations contribute to Parkinson's disease?
Joanne Clark
Parkinson's disease, 2011
View PDFchevron_right
Nuclear and Mitochondrial Genome, Epigenome and Gut Microbiome: Emerging Molecular Biomarkers for Parkinson’s Disease
Gleyce Cabral
International Journal of Molecular Sciences
View PDFchevron_right
A different vision of translational research in biomarker discovery: a pilot study on circulatory mitochondrial proteins as Parkinson’s disease potential biomarkers
Sandra Anjo
Translational Neurodegeneration
View PDFchevron_right
Sequence Analysis of the Entire Mitochondrial Genome in Parkinson's Disease
Giovanni Manfredi
Biochemical and Biophysical Research Communications, 2002
View PDFchevron_right
Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease
Mei Gu
Annals of Neurology, 1998
View PDFchevron_right
Mitochondrial DNA heteroplasmy distinguishes disease manifestation in PINK1- and PRKN-linked Parkinson’s disease
Andrew Hicks
View PDFchevron_right
Translational approaches to restoring mitochondrial function in Parkinson's disease
Heather Mortiboys
FEBS letters, 2017
View PDFchevron_right
A novel screen for nuclear mitochondrial gene associations with Parkinson?s disease
Peter Silburn
Journal of Neural Transmission, 2004
View PDFchevron_right
Mitochondrial damage-associated inflammation highlights biomarkers in PRKN/PINK1 parkinsonism
Micol Avenali
Brain, 2020
View PDFchevron_right
Genotyping Parkinson Disease-Associated Mitochondrial Polymorphisms
Tammy Ellis
Clinical Medicine & Research, 2004
View PDFchevron_right
Longitudinal Changes in Mitochondrial DNA Copy Number and Telomere Length in Patients with Parkinson’s Disease
Marisol López-López
Genes
View PDFchevron_right
Fragile Mitochondrial DNA: The Missing Link in the Apoptotic Neuronal Cell Death in Parkinson's Disease
M. Hayakawa
Biochemical and Biophysical Research Communications, 1997
View PDFchevron_right
Novel susceptibility genes and molecular mechanisms identified in relation to mitochondrial dysfunctions in Parkinson’s disease
Dunhui Li
View PDFchevron_right
Environmental and Genetic Variables Influencing Mitochondrial Health and Parkinson’s Disease Penetrance
Andrew Hicks
Parkinson's Disease
View PDFchevron_right
Mitochondrial DNA heteroplasmy distinguishes disease manifestation in PINK1/PRKN-linked Parkinson’s disease
Andrew Hicks
Brain
View PDFchevron_right
Genetic findings in Parkinson’s disease and translation into treatment: a leading role for mitochondria?
Christine Van Broeckhoven
Genes, Brain and Behavior, 2008
View PDFchevron_right
Mitochondrial remodeling in human skin fibroblasts from sporadic male Parkinson's disease patients uncovers metabolic and mitochondrial bioenergetic defects
Cláudia Deus
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2019
View PDFchevron_right